Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales23 00623 92327 88930 11931 09932 276
EBITDA8 0457 0289 63210 22210 55910 977
Operating profit (EBIT)6 5945 7297 7718 2928 6569 197
Pre-Tax Profit (EBT)2 96810 5261 9396 2477 2377 893
Net income2 7568 4229124 3814 7845 162
P/E ratio24,37,9783,118,816,415,4
EPS (GBp )56,717218,888,6101108
Dividend per Share (GBp )80,080,080,080,080,481,5
Yield5,81%5,83%5,12%4,81%4,84%4,90%
Reference price (GBp )1376137315621663.51663.51663.5
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt14 37710 72713 80413 92913 21212 078
Finance------
Operating income (EBITDA)8 0457 0289 63210 22210 55910 977
Leverage
(Debt/EBITDA)
1,79x1,53x1,43x1,36x1,25x1,10x
Capital Expenditure1 1881 3801 5431 8001 7291 775
Book Value Per Share (BVPS)87,6 PNC106 PNC22,9 PNC51,2 PNC71,0 PNC93,2 PNC
Cash Flow per Share108 PNC53,2 PNC132 PNC139 PNC149 PNC156 PNC
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 81 809 M GBP -
Entreprise Value (EV) 95 738 M GBP 95 020 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 18,8x 16,4x
Capitalization / Revenue 2,72x 2,63x
EV / Revenue 3,18x 3,06x
EV / EBITDA 9,37x 9,00x
Yield (DPS / Price) 4,81% 4,84%
Price to book (Price / BVPS) 32,5x 23,4x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 27,5% 27,8%
operating Leverage (Delta EBIT / Delta Sales) 0,84x 1,35x
Net Margin (Net Profit / Revenue) 14,5% 15,4%
ROA (Net Profit / Asset) 9,36% 10,4%
ROE (Net Profit / Equities) 339% 241%
Rate of Dividend 90,3% 79,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,98% 5,56%
Cash Flow / Sales 22,7% 23,6%
Capital Intensity (Assets / Sales) 1,55x 1,49x
Financial Leverage (Net Debt / EBITDA) 1,36x 1,25x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend